Bitcoin Price Prediction as Biden’s Decision on SEC Crypto Rules Looms – Will BTC Rally?
Bitcoin Price Prediction
As the deadline for President Biden’s decision on the SEC’s cryptocurrency regulations approaches, Bitcoin’s market response remains cautious. Currently trading at $68,400, the cryptocurrency has experienced a slight decline of 0.50%.
This movement could indicate a bearish trend in Bitcoin price predictions , suggesting that investors are weighing the potential impacts of regulatory changes on the digital asset’s value.
Biden’s Decision on SEC’s Crypto Rules Nears as Veto Deadline Approaches
President Joe Biden is approaching a crucial deadline to decide on a resolution that could overturn the U.S. Securities and Exchange Commission’s (SEC) Staff Accounting Bulletin 121 (SAB 121).
The resolution, which has already been approved by both the House of Representatives and the Senate, is threatened with a veto by the White House.
President Biden has until June 3 to act on the Congressional decision, which challenges the SEC’s controversial crypto regulations intended to govern the handling of digital assets by brokers.
Potential Outcomes of Presidential Action
The Chamber of Digital Commerce outlines three potential actions President Biden could take: veto the resolution, sign it into law, or do nothing and let the resolution become law by default if Congress is in session.
A presidential veto would likely be the final step in the effort to overturn SAB 121, as Congress probably lacks the two-thirds majority required to override a veto.
If signed or left unsigned with Congress in session, the resolution would nullify SAB 121, preventing the SEC from implementing a similar rule in the future.
Implications for Bitcoin and Crypto Regulation
This decision is pivotal for the cryptocurrency market, including Bitcoin, as it will influence how digital assets are regulated in the United States. The outcome could impact investor confidence and market stability, as clear regulatory frameworks are often seen as essential for the mainstream adoption of cryptocurrencies.
Additionally, the House has moved forward with the Financial Innovation and Technology for the 21st Century (FIT21) Act, which aims to establish a more comprehensive regulatory framework for digital assets.
The Biden administration has shown a willingness to collaborate with Congress on this issue, suggesting a possible softening of its stance towards crypto regulation.
Bitcoin Price Prediction
Bitcoin is currently trading at $68,400, marking a modest drop of 0.50%, signalling a bearish Bitcoin price prediction . The digital currency sits just above its pivotal point at $68,500, which is critical in determining its short-term movement.
Bitcoin’s immediate resistance levels are $69,600, followed by $70,650 and $71,950. These markers represent key hurdles that Bitcoin needs to overcome to sustain an upward trajectory.
On the downside, immediate support lies at $67,265, with further cushions at $66,380 and $65,144. These levels are vital for holding Bitcoin’s price in case of a downturn.
Technical indicators suggest a nuanced picture. The Relative Strength Index (RSI) is at 47, indicating a neutral market sentiment that leans neither towards overbought nor oversold conditions.
Meanwhile, the 50-day Exponential Moving Average (EMA) stands at $68,737, slightly above the current price, hinting at potential resistance.
Conclusion:
- Bitcoin’s current stance is delicately balanced at $68,502, with pivotal support and resistance levels nearby.
- Bearish potential below $68,500 with substantial support levels to watch; bullish above this mark could target higher resistance.
- Neutral RSI and close 50 EMA suggest cautious trading, with potential for shifts in market direction based on upcoming price actions.
The technical landscape for Bitcoin shows a currency at a crossroads, with potential shifts heavily reliant on its ability to maintain or breach the $68,500 level.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. non-farm payrolls surge by 165,000 in October, far exceeding expectations! Unemployment rate unexpectedly drops to 4.1%, December rate hike expectations intensify
In October, US non-farm payrolls increased by 165,000, which is 2.5 times the Wall Street median forecast of 65,000 and represents an exceptionally strong deviation of about 5 standard deviations, exceeding the upper limit of all institutional forecast ranges. The unemployment rate unexpectedly fell from 4.2% to 4.1%, while the market had expected it to remain unchanged; average hourly wages also accelerated year-on-year growth to 3.1%. Meanwhile, the previous two months' non-farm payrolls were revised upwards by a total of 84,000. Following the release of the data, the yield on 2-year US Treasury bonds rose by 7 basis points, and the pricing of the probability of a Fed rate hike in December climbed to 70%.
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion
The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Crypto prices
More
